Patents by Inventor Matvey Lukashev

Matvey Lukashev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
    Publication number: 20240368195
    Abstract: The present disclosure relates to copper complexes, pharmaceutical compositions comprising these complexes, chemical processes for preparing these complexes, and their use in the treatment of neurodegenerative disease, e.g., amyotrophic lateral sclerosis (ALS).
    Type: Application
    Filed: April 23, 2024
    Publication date: November 7, 2024
    Inventors: Matvey Lukashev, Alexei Pushechnikov, Peter Demin, Kyle DENTON
  • Copper complexes for treatment of neurodegenerative disorders
    Patent number: 12012422
    Abstract: The present disclosure relates to copper complexes, pharmaceutical compositions comprising these complexes, chemical processes for preparing these complexes, and their use in the treatment of neurodegenerative disease, e.g., amyotrophic lateral sclerosis (ALS).
    Type: Grant
    Filed: August 26, 2021
    Date of Patent: June 18, 2024
    Assignee: ALS THERAPY DEVELOPMENT INSTITUTE
    Inventors: Matvey Lukashev, Alexei Pushechnikov, Peter Demin, Kyle Denton
  • COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
    Publication number: 20240016879
    Abstract: The present disclosure relates to the use of CuPTSM in methods and compositions for treating subjects with a neurodegenerative disease. Subjects with a neurodegenerative disease can have, e.g., amyotrophic lateral sclerosis (ALS).
    Type: Application
    Filed: April 19, 2023
    Publication date: January 18, 2024
    Inventors: Steven Perrin, Fernando G. Vieira, Alan Gill, Theo Hatzipetros, Kyle Denton, Matvey Lukashev
  • Copper complexes for treatment of neurodegenerative disorders
    Patent number: 11660324
    Abstract: The present disclosure relates to the use of CuPTSM in methods and compositions for treating subjects with a neurodegenerative disease. Subjects with a neurodegenerative disease can have, e.g., amyotrophic lateral sclerosis (ALS).
    Type: Grant
    Filed: July 24, 2020
    Date of Patent: May 30, 2023
    Assignee: ALS THERAPY DEVELOPMENT INSTITUTE
    Inventors: Steven Perrin, Fernando G. Vieira, Alan Gill, Theo Hatzipetros, Kyle Denton, Matvey Lukashev
  • COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
    Publication number: 20230054997
    Abstract: The present disclosure relates to copper complexes, pharmaceutical compositions comprising these complexes, chemical processes for preparing these complexes, and their use in the treatment of neurodegenerative disease, e.g., amyotrophic lateral sclerosis (ALS).
    Type: Application
    Filed: August 26, 2021
    Publication date: February 23, 2023
    Inventors: Matvey Lukashev, Alexei Pushechnikov, Peter Demin, Kyle DENTON
  • COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
    Publication number: 20210038676
    Abstract: The present disclosure relates to the use of CuPTSM in methods and compositions for treating subjects with a neurodegenerative disease. Subjects with a neurodegenerative disease can have, e.g., amyotrophic lateral sclerosis (ALS).
    Type: Application
    Filed: July 24, 2020
    Publication date: February 11, 2021
    Inventors: Steven Perrin, Fernando G. Vieira, Alan Gill, Theo Hatzipetros, Kyle Denton, Matvey Lukashev
  • Treatment of Neurodegeneration and Neuroinflammation
    Publication number: 20190195860
    Abstract: Methods of treating a subject having a condition characterized by at least one of neurodegeneration and neuroin-flammation are provided. Methods of reducing astrogliosis in a subject having a condition characterized by increased astrogliosis are also provided. Methods of providing neuroprotection to a subject in need thereof are also provided.
    Type: Application
    Filed: November 29, 2018
    Publication date: June 27, 2019
    Applicant: BIOGEN MA INC.
    Inventor: Matvey Lukashev
  • Treatment of Neurodegeneration and Neuroinflammation
    Publication number: 20150132747
    Abstract: Methods of treating a subject having a condition characterized by at least one of neurodegeneration and neuroinflammation are provided. Methods of reducing astrogliosis in a subject having a condition characterized by increased astrogliosis are also provided. Methods of providing neuroprotection to a subject in need thereof are also provided.
    Type: Application
    Filed: November 13, 2014
    Publication date: May 14, 2015
    Inventor: Matvey Lukashev
  • TREATMENT OF NEURODEGENERATION AND NEUROINFLAMMATION
    Publication number: 20120165404
    Abstract: Methods of treating a subject having a condition characterized by at least one of neurodegeneration and neuroinflammation are provided. Methods of reducing astrogliosis in a subject having a condition characterized by increased astrogliosis are also provided. Methods of providing neuroprotection to a subject in need thereof are also provided.
    Type: Application
    Filed: April 29, 2010
    Publication date: June 28, 2012
    Applicant: Biogen Idec MA Inc.
    Inventor: Matvey Lukashev
  • Mouse arrays and kits comprising the same
    Patent number: 6077673
    Abstract: Mouse arrays and methods for their use are provided. The subject arrays include a plurality of polynucleotide spots, each of which is made up of a polynucleotide probe composition of unique polynucleotides corresponding to a key mouse gene. The subject arrays find use in hybridization assays, particularly in assays for the identification of differential gene expression of key mouse genes of interest.
    Type: Grant
    Filed: December 28, 1998
    Date of Patent: June 20, 2000
    Assignee: Clontech Laboratories, Inc.
    Inventors: Alex Chenchik, Matvey Lukashev